{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T12:30:08Z","timestamp":1792499408000,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:00:00Z","timestamp":1628812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:00:00Z","timestamp":1628812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1038\/s41433-021-01723-7","type":"journal-article","created":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T15:03:23Z","timestamp":1628867003000},"page":"284-293","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Imaging endpoints for clinical trials in MacTel type 2"],"prefix":"10.1038","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3691-291X","authenticated-orcid":false,"given":"Daniel","family":"Pauleikhoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurenz","family":"Pauleikhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0999-9802","authenticated-orcid":false,"given":"Emily Y.","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,13]]},"reference":[{"key":"1723_CR1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.preteyeres.2012.11.002","volume":"34","author":"P Charbel Issa","year":"2013","unstructured":"Charbel Issa P, Gillies MC, Chew EY, Bird AC, Heeren TF, Peto T, et al. Macular telangiectasia type 2. Prog Retin Eye Res. 2013;34:49\u201377.","journal-title":"Prog Retin Eye Res"},{"key":"1723_CR2","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1016\/j.ophtha.2010.04.001","volume":"117","author":"MB Powner","year":"2010","unstructured":"Powner MB, Gillies MC, Tretiach M, Scott A, Guymer RH, Hageman GS, et al. Perifoveal M\u00fcller cell depletion in a case of macular telangiectasia type 2. Ophthalmology. 2010;117:2407\u201316.","journal-title":"Ophthalmology"},{"key":"1723_CR3","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1016\/j.ophtha.2013.04.013","volume":"120","author":"MB Powner","year":"2013","unstructured":"Powner MB, Gillies MC, Zhu M, Vevis K, Hunyor AP, Fruttiger M. Loss of M\u00fcller\u2019s cells and photoreceptors in macular telangiectasia type 2. Ophthalmology. 2013;120:2344\u201352.","journal-title":"Ophthalmology"},{"key":"1723_CR4","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1056\/NEJMoa1815111","volume":"381","author":"ML Gantner","year":"2019","unstructured":"Gantner ML, Eade K, Wallace M, Handzlik MK, Fallon R, Trombley J, et al. Serine and lipid metabolism in macular disease and peripheral neuropathy. N Engl J Med. 2019;381:1422\u201333.","journal-title":"N Engl J Med"},{"key":"1723_CR5","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/archopht.1982.01030030773010","volume":"100","author":"JD Gass","year":"1982","unstructured":"Gass JD, Oyakawa RT. Idiopathic juxtafoveolar retinal telangiectasis. Arch Ophthalmol. 1982;100:769\u201380.","journal-title":"Arch Ophthalmol"},{"key":"1723_CR6","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0161-6420(93)31447-8","volume":"100","author":"JDM Gass","year":"1993","unstructured":"Gass JDM, Blodi BA. Idiopathic juxtafoveolar retinal telangiectasis: update of classification and follow-up study. Ophthalmology. 1993;100:1536\u201346.","journal-title":"Ophthalmology"},{"key":"1723_CR7","doi-asserted-by":"crossref","first-page":"6568","DOI":"10.1167\/iovs.12-9756","volume":"53","author":"SD Esposti","year":"2012","unstructured":"Esposti SD, Egan C, Bunce C, Moreland JD, Bird AC, Robson RG. Macular pigment parameters in patients with macular telangiectasia (MacTel) and normal subjects: implications of a novel analysis. Investig Ophthalmol Vis Sci. 2012;53:6568\u201375.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1723_CR8","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/IAE.0b013e3181bd2d38","volume":"30","author":"MB Zeimer","year":"2010","unstructured":"Zeimer MB, Padge B, Heimes B, Pauleikhoff D. Idiopathic macular telangiectasia type 2: distribution of macular pigment and functional investigations. Retina. 2010;30:586\u201395.","journal-title":"Retina"},{"key":"1723_CR9","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1167\/iovs.07-0636","volume":"49","author":"P Charbel Issa","year":"2008","unstructured":"Charbel Issa P, Berendschot TT, Staurenghi G, Holz FG, Scholl HP. Confocal blue reflectance imaging in type 2 idiopathic macular telangiectasia. Investig Ophthalmol Vis Sci. 2008;49:1172\u20137.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1723_CR10","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1097\/IAE.0000000000001728","volume":"38","author":"FB Sallo","year":"2018","unstructured":"Sallo FB, Leung I, Zeimer M, Clemons TE, Dubis AM, Fruttiger M, et al. Abnormal retinal reflectivity to short-wavelength light in type 2 idiopathic macular teleangiectasis. Retina. 2018;38:S79\u201388.","journal-title":"Retina"},{"key":"1723_CR11","doi-asserted-by":"publisher","unstructured":"Tzaridis S, Heeren TFC, Mai C, Thiele S, Holz FG, Charbel Issa P, et al. Right-angled vessels in macular telangiectasia type 2. Br J Ophthalmol. 2019. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-313364. Online ahead of print.","DOI":"10.1136\/bjophthalmol-2018-313364"},{"key":"1723_CR12","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1001\/archopht.124.10.1410","volume":"124","author":"A Gaudric","year":"2006","unstructured":"Gaudric A, Ducos de Lahitte G, Cohen SY, Massin P, Haouchine B. Optical coherence tomography in group 2A idiopathic juxtafoveolar retinal telangiectasis. Arch Ophthalmol. 2006;124:1410\u20139.","journal-title":"Arch Ophthalmol"},{"key":"1723_CR13","doi-asserted-by":"crossref","first-page":"7889","DOI":"10.1167\/iovs.12-10765","volume":"53","author":"FB Sallo","year":"2012","unstructured":"Sallo FB, Peto T, Egan C, Wolf-Schnurrbusch UE, Clemons TE, Gillies MC, et al. The IS\/OS junction layer in the natural history of type 2 idiopathic macular telangiectasia. Investig Ophthalmol Vis Sci. 2012;53:7889\u201395.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1723_CR14","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/IAE.0000000000000365","volume":"35","author":"FB Sallo","year":"2015","unstructured":"Sallo FB, Leung I, Clemons TE, Peto T, Bird AC, Pauleikhoff D. Multimodal imaging in type 2 idiopathic macular teleangiectasis. Retina. 2015;35:742\u20139.","journal-title":"Retina"},{"key":"1723_CR15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1167\/iovs.17-21834","volume":"58","author":"D Mukherjee","year":"2017","unstructured":"Mukherjee D, Lad EM, Vann RR, Jaffe SJ, Clemons TE, Friedlander M, et al. Correlation between macular integrity assessment and optical coherence tomography imaging of ellipsoid zone in macular telangiectasia type 2. Investig Ophthalmol Vis Sci. 2017;58:291\u20139.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1723_CR16","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1097\/IAE.0000000000001715","volume":"38","author":"TFC Heeren","year":"2018","unstructured":"Heeren TFC, Kitka D, Florea D, Clemons TE, Chew EY, Bird AC, et al. Longitudinal correlation of ellipsoid zone loss and functional loss in Macular Telangiectasia Type 2. Retina. 2018;38:S20\u201326.","journal-title":"Retina"},{"key":"1723_CR17","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/IAE.0000000000001746","volume":"38","author":"M Okada","year":"2018","unstructured":"Okada M, Robson AG, Egan CA, Sallo FB, Esposti SD, Heeren TFC, et al. Electrophysiological characterization of Macular Telangiectasia Type 2 and structure-function correlation. Retina. 2018;38:S33\u201342.","journal-title":"Retina"},{"key":"1723_CR18","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1097\/IAE.0000000000001697","volume":"38","author":"T Peto","year":"2018","unstructured":"Peto T, Heeren TFC, Clemons TE, Sallo FB, Leung I, Chew EY, et al. Correlation of clinical and functional progression with visual acuity loss in Macular Telangiectasia Type 2. MacTel Project Report No. 6\u2013The MacTel Research Group. Retina. 2018;38:S8\u201313.","journal-title":"Retina"},{"key":"1723_CR19","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/aos.14110","volume":"97","author":"D Pauleikhoff","year":"2019","unstructured":"Pauleikhoff D, Bonelli R, Dubis AM, Gunnemann F, Rothaus K, Charbel Issa P, et al. Progression characteristics of ellipsoid zone loss in macular teleangiectasia type 2. Acta Ophthalmol. 2019;97:998\u20131005.","journal-title":"Acta Ophthalmol"},{"key":"1723_CR20","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/bjophthalmol-2020-317997","volume":"105","author":"S Mueller","year":"2021","unstructured":"Mueller S, Gunnemann F, Rothaus K, Book M, Faatz H, Bird AC, et al. Incidence and phenotypical variation of outer retina-associated hyperreflectivity in macular telangiectasia type 2. Br J Ophthalmol. 2021;105:573\u20136.","journal-title":"Br J Ophthalmol"},{"key":"1723_CR21","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1097\/IAE.0000000000000799","volume":"35","author":"A Gaudric","year":"2015","unstructured":"Gaudric A, Krivosic V, Tadayoni R. Outer retina capillary invasion and ellipsoid zone loss in Macular Teleangiectasia Type 2 imaged by OCT angiography. Retina. 2015;35:2300\u20136.","journal-title":"Retina"},{"key":"1723_CR22","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1097\/IAE.0000000000002289","volume":"38","author":"RF Spaide","year":"2018","unstructured":"Spaide RF, Yannuzzi LA, Maloca PM. Retinal-choroidal anastomosis in macular teleangictasis type 2. Retina. 2018;38:1920\u20139.","journal-title":"Retina"},{"key":"1723_CR23","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/IAE.0000000000002619","volume":"40","author":"MP Breazzano","year":"2020","unstructured":"Breazzano MP, Yannuzzi LA, Spaide RF. Characterizing retinal-choroidal anastomosis in macular teleangiectasia type 2 with optical coherence tomography angiography. Retina. 2020;40:92\u20138.","journal-title":"Retina"},{"key":"1723_CR24","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/s00417-019-04323-0","volume":"257","author":"D Pauleikhoff","year":"2019","unstructured":"Pauleikhoff D, Gunnemann F, Book M, Rothaus K. Progression of vascular changes in macular telangiectasia type 2: comparison between SD-OCT and OCT angiography. Graefes Arch Clin Exp Ophthalmol. 2019;257:1381\u201392.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1723_CR25","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1136\/bjophthalmol-2020-316021","volume":"105","author":"S Tzaridis","year":"2021","unstructured":"Tzaridis S, Hess K, Friedlander M, Holz FG. Optical coherence tomography-angiography for monitoring neovascularisations in macular telangiectasia type 2. Br J Ophthalmol. 2021;105:735\u201340.","journal-title":"Br J Ophthalmol"},{"key":"1723_CR26","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.ophtha.2020.03.040","volume":"127","author":"TFC Heeren","year":"2020","unstructured":"Heeren TFC, Chew EY, Clemons T, Fruttiger M, Balaskas K, Schwartz R, et al. MacTel Study Group. Macular telangiectasia type 2 - visual acuity, disease endstage and the MacTel area. MacTel Project Report No. 8. Ophthalmology. 2020;127:1539\u201348.","journal-title":"Ophthalmology"},{"key":"1723_CR27","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/IAE.0000000000000863","volume":"36","author":"P Charbel Issa","year":"2016","unstructured":"Charbel Issa P, Heeren TF, Kupitz EH, Holz FG, Berendschot TT. Very early disease manifestations of macular telangiectasia type 2. Retina. 2016;36:524\u201334.","journal-title":"Retina"},{"key":"1723_CR28","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1167\/iovs.15-16915","volume":"56","author":"TF Heeren","year":"2015","unstructured":"Heeren TF, Clemons T, Scholl HP, Bird AC, Holz FG, Charbel Issa P. Progression of vision loss in macular telangiectasia type 2. Investig Ophthalmol Vis Sci. 2015;56:3905\u201312.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1723_CR29","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1600-0420.2007.01041.x","volume":"86","author":"P Charbel Issa","year":"2008","unstructured":"Charbel Issa P, Finger RP, Helb HM, Holz FG, Scholl HP. A new diagnostic approach in patients with type 2 macular telangiectasia: confocal reflectance imaging. Acta Ophthalmol. 2008;86:464\u20135.","journal-title":"Acta Ophthalmol"},{"key":"1723_CR30","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/IAE.0b013e3181b9f11e","volume":"30","author":"F Bottoni","year":"2010","unstructured":"Bottoni F, Eandi CM, Pedenovi S, Staurenghi G. Integrated clinical evaluation of Type 2A idiopathic juxtafoveolar retinal telangiectasis. Retina. 2010;30:317\u201326.","journal-title":"Retina"},{"key":"1723_CR31","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3928\/23258160-20150101-26","volume":"46","author":"A Jindal","year":"2015","unstructured":"Jindal A, Choudhury H, Pathengay A, Flynn HW Jr. A novel clinical sign in macular telangiectasia type 2. Ophthalmic Surg Lasers Imaging Retin. 2015;46:134\u20136.","journal-title":"Ophthalmic Surg Lasers Imaging Retin"},{"key":"1723_CR32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/IAE.0000000000001754","volume":"38","author":"M Okada","year":"2018","unstructured":"Okada M, Heeren TFC, Egan CA, Rocco V, Bonelli R, Fruttiger M. Effect of dark adaptation and bleaching on Blue Light Reflectance imaging in Macular Teleangiectasia Type 2. Retina. 2018;38:89\u201396.","journal-title":"Retina"},{"key":"1723_CR33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ajo.2021.03.022","volume":"228","author":"F Pauleikhoff","year":"2021","unstructured":"Pauleikhoff L, Heeren TFC, Gliem M, Lim E, Pauleikhoff D, Holz FG, et al. Fundus autofluorescence imaging in macular telangiectasia type 2 - MacTel Study Report Number 9: fundus autofluorescence in macular telangiectasia type 2. Am J Ophthalmol. 2021;228:27\u201334.","journal-title":"Am J Ophthalmol"},{"key":"1723_CR34","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1097\/IAE.0b013e3181e096dd","volume":"3","author":"MB Zeimer","year":"2010","unstructured":"Zeimer MB, Kr\u00f6mer I, Spital G, Lommatzsch A, Pauleikhoff D. Macular telangiectasia: patterns of distribution of macular pigment and response to supplementation. Retina. 2010;3:1282\u201393.","journal-title":"Retina"},{"key":"1723_CR35","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/IAE.0000000000000023","volume":"34","author":"MB Zeimer","year":"2014","unstructured":"Zeimer MB, Spital G, Heimes B, Lommatzsch A, Pauleikhoff D. Macular telangiectasia-changes in macular pigment optical density during a 5-year follow-up. Retina. 2014;34:920\u20138.","journal-title":"Retina"},{"key":"1723_CR36","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/IAE.0000000000000752","volume":"36","author":"MB Zeimer","year":"2016","unstructured":"Zeimer MB, Sallo FB, Spital G, Heimes B, Lommatzsch A, Pauleikhoff D. Correlation of optical coherence tomography and macular pigment optical density measurements in type 2 macular teleangiectasia. Retina. 2016;36:535\u201344.","journal-title":"Retina."},{"key":"1723_CR37","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.exer.2007.10.022","volume":"8","author":"T Theelen","year":"2008","unstructured":"Theelen T, Berendschot TT, Boon CJ, Hoyng CB, Klevering BJ. Analysis of visual pigment by fundus autofluorescence. Exp Eye Res. 2008;8:296\u2013304.","journal-title":"Exp Eye Res"},{"key":"1723_CR38","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s00417-006-0289-3","volume":"244","author":"M Trieschmann","year":"2006","unstructured":"Trieschmann M, Heimes B, Hense HW, Pauleikhoff D. Macular pigment optical density measurement in autofluorescence imaging: comparison of one- and two-wavelength methods. Graefes Arch Clin Exp Ophthalmol. 2006;244:1565\u201374.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1723_CR39","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/IAE.0b013e31816d81aa","volume":"28","author":"HM Helb","year":"2008","unstructured":"Helb HM, Charbel Issa P, RL VDV, Berendschot TT, Scholl HP, Holz FG. Abnormal macular pigment distribution in type 2 idiopathic macular telangiectasia. Retina. 2008;28:808\u201316.","journal-title":"Retina"},{"key":"1723_CR40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.exer.2009.02.006","volume":"89","author":"P Charbel Issa","year":"2009","unstructured":"Charbel Issa P, van der Veen RL, Stijfs A, Holz FG, Scholl HP, Berendschot TT. Quantification of reduced macular pigment optical density in the central retina in macular telangiectasia type 2. Exp Eye Res. 2009;89:25\u201331.","journal-title":"Exp Eye Res"},{"key":"1723_CR41","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1167\/iovs.12-10580","volume":"5","author":"FB Sallo","year":"2012","unstructured":"Sallo FB, Peto T, Egan C, Wolf-Schnurrbusch UE, Clemons TE, Gillies MC, et al. \u201cEn face\u201d OCT imaging of the IS\/OS junction line in type 2 idiopathic macular telangiectasia. Investig Ophthalmol Vis Sci. 2012;5:6145\u201352.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1723_CR42","first-page":"2468","volume":"19","author":"V Krivosic","year":"2020","unstructured":"Krivosic V, Lavia C, Aubineau A, Tadayoni R, Alain Gaudric A. OCT of outer retinal hyperreflectivity, neovascularization, and pigment in macular telangiectasia type 2. Ophthalmol Retina. 2020;19:2468\u20136530.","journal-title":"Ophthalmol Retina"},{"key":"1723_CR43","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1167\/iovs.62.3.6","volume":"62","author":"S Tzaridis","year":"2021","unstructured":"Tzaridis S, Friedlander M, Macular Telangiectasia Type 2-Phase 2 CNTF Research Group. Functional relevance of hyper-reflectivity in macular telangiectasia type 2. Investig Ophthalmol Vis Sci. 2021;62:6. https:\/\/doi.org\/10.1167\/iovs.62.3.6.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1723_CR44","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/IAE.0000000000002619","volume":"40","author":"MP Breazzano","year":"2020","unstructured":"Breazzano MP, Yannuzzi LA, Spaide RF. Genesis of retinal-choroidal anastomosis in macular telangiectasia type 2: a longitudinal analysis. Retina. 2020;40:92\u20138.","journal-title":"Retina"},{"key":"1723_CR45","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.ajo.2014.12.013","volume":"159","author":"EY Chew","year":"2015","unstructured":"Chew EY, Clemons TE, Peto T, Sallo FB, Ingerman A, Tao W, et al. Ciliary neurotrophic factor for macular telangiectasia type 2: results from a phase 1 safety trial. Am J Ophthalmol. 2015;159:659\u201366.","journal-title":"Am J Ophthalmol"},{"key":"1723_CR46","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ophtha.2018.09.041","volume":"126","author":"EY Chew","year":"2019","unstructured":"Chew EY, Clemons TE, Jaffe GJ, Johnson CA, Farsiu S, Lad EM, et al. Effect of ciliary neurotrophic factor on retinal neurodegeneration in patients with macular telangiectasia type 2: a randomized clinical trial. Ophthalmology. 2019;126:540\u20139.","journal-title":"Ophthalmology"},{"key":"1723_CR47","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.1364\/OE.20.004710","volume":"20","author":"Y Jia","year":"2012","unstructured":"Jia Y, Tan O, Tokayer J, Potsaid B, Wang Y, Liu JJ, et al. Split-spectrum amplitude-decorrelation angiography with optical coherence tomography. Opt Express. 2012;20:4710\u201325.","journal-title":"Opt Express"},{"key":"1723_CR48","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1097\/IAE.0000000000000868","volume":"35","author":"M Zeimer","year":"2015","unstructured":"Zeimer M, Gutfleisch M, Heimes B, Spital G, Lommatzsch A, Pauleikhoff D. Association between changes in macular vasculature in optical coherence tomography- and fluorescein-angiography and distribution of macular pigment in type 2 idiopathic macular teleangiectasia. Retina. 2015;35:2307\u201316.","journal-title":"Retina"},{"key":"1723_CR49","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1055\/s-0043-118346","volume":"234","author":"H Faatz","year":"2017","unstructured":"Faatz H, Rothaus K, Gunnemann F, Gutfleisch M, Heimes-Bussmann B, Lommatzsch A, et al. Changes in OCT angiography of Type 2 CNV in neovascular AMD during anti-VEGF treatment. Klin Monatsbl Augenheilkd. 2017;234:1125\u201331.","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"1723_CR50","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1038\/s41433-019-0429-8","volume":"33","author":"H Faatz","year":"2019","unstructured":"Faatz H, Farecki ML, Rothaus, Gunnemann F, Gutfleisch M, Lommatzsch A. Optical coherence tomography angiography of type 1 and 2 neovascularisations in age-related macular degeneration under anti-VEGF therapy: Evaluation of a new quantitative method. Eye. 2019;33:1466\u201371.","journal-title":"Eye"},{"key":"1723_CR51","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1097\/IAE.0000000000000840","volume":"35","author":"Q Zhang","year":"2015","unstructured":"Zhang Q, Wang RK, Chen CL, Legarreta AD, Durbin MK, An L, et al. Swept source optical coherence tomography angiography of neovascular macular teleangiectasia type 2. Retina. 2015;35:2285\u201399.","journal-title":"Retina"},{"key":"1723_CR52","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1167\/iovs.16-20976","volume":"58","author":"AP Runkle","year":"2017","unstructured":"Runkle AP, Kaiser PK, Srivastava SK, Schachat AP, Reese JL, Ehlers JP. OCT angiography and ellipsoid zone mapping of macular telangiectasia type 2 from the AVATAR study. Investig Ophthalmol Vis Sci. 2017;58:3683\u20139.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1723_CR53","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/IAE.0000000000001842","volume":"38","author":"I Leung","year":"2018","unstructured":"Leung I, Sallo FB, Bonelli R, Clemons TE, Pauleikhoff D, Chew EY, et al. Characteristics of pigmented lesions in type 2 idiopathic macular teleangiectasia. Retina. 2018;38:43\u201350.","journal-title":"Retina"},{"key":"1723_CR54","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/978-3-030-27378-1_41","volume":"1185","author":"TA Ray","year":"2019","unstructured":"Ray TA, Cochran KJ, Kay JN. The enigma of CRB1 and CRB1 retinopathies. Adv Exp Med Biol. 2019;1185:251\u20135.","journal-title":"Adv Exp Med Biol"},{"key":"1723_CR55","doi-asserted-by":"crossref","first-page":"e137317","DOI":"10.1172\/jci.insight.137317","volume":"5","author":"A Usui-Ouchi","year":"2020","unstructured":"Usui-Ouchi A, Usui Y, Kurihara T, Aguilar E, Dorrell MI, Ideguchi Y, et al. Retinal microglia are critical for subretinal neovascular formation. JCI Insight. 2020;5:e137317.","journal-title":"JCI Insight"},{"key":"1723_CR56","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ophtha.2019.11.004","volume":"127","author":"RF Spaide","year":"2020","unstructured":"Spaide RF, Jaffe GJ, Sarraf D, Freund KB, Sadda SR, Staurenghi G, et al. Consensus nomenclature for reporting neovascular age-related macular degeneration data: consensus on neovascular age-related macular degeneration nomenclature study group. Ophthalmology. 2020;127:616\u201336.","journal-title":"Ophthalmology"},{"key":"1723_CR57","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1097\/IAE.0000000000000715","volume":"35","author":"EH Kupitz","year":"2015","unstructured":"Kupitz EH, Heeren TFC, Holz FG, Charbel Issa P. Poor long-term outcome of Anti-VEGF-Therapy in nonproliferative Macular Teleangiectasia Type 2. Retina. 2015;35:2619\u201326.","journal-title":"Retina"},{"key":"1723_CR58","doi-asserted-by":"publisher","unstructured":"Tapia Quijada HE, Mantolan Sarmiento C, G\u00f3mez Perera S, Serrano Garc\u00eda M, Betancor Caro N, Haro \u00c1lvarez B. OCT-angiography for diagnosis and response to treatment of subretinal neovascularization secondary to idiopathic macular telangiectasia type 2. Arch Soc Esp Oftalmol. 2021. https:\/\/doi.org\/10.1016\/j.oftal.2020.11.020. Online ahead of print.","DOI":"10.1016\/j.oftal.2020.11.020"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01723-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01723-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01723-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,19]],"date-time":"2022-02-19T08:14:36Z","timestamp":1645258476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-021-01723-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,13]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["1723"],"URL":"https:\/\/doi.org\/10.1038\/s41433-021-01723-7","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,13]]},"assertion":[{"value":"15 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}